A Phase I, Single Centre, Open, Randomised, Parallel Study to Evaluate the Pharmacokinetics and Tolerability of Multiple Doses of Eslicarbazepine Acetate and Oxcarbazepine in Healthy Subjects

Trial Profile

A Phase I, Single Centre, Open, Randomised, Parallel Study to Evaluate the Pharmacokinetics and Tolerability of Multiple Doses of Eslicarbazepine Acetate and Oxcarbazepine in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 31 Dec 2014

At a glance

  • Drugs Eslicarbazepine acetate (Primary) ; Oxcarbazepine (Primary)
  • Indications Epilepsy; Neuropathic pain; Partial epilepsies
  • Focus Pharmacokinetics
  • Sponsors Bial
  • Most Recent Events

    • 14 Apr 2011 Results presented at the 63rd Annual Meeting of the American Academy of Neurology.
    • 05 Dec 2010 Data were presented at the 2010 annual meeting of the American Epilepsy Society (AES), according to a Sunovion Pharmaceuticals media release.
    • 14 May 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top